Activists call for adding new Alzheimer's drug to Medicare coverage

Protesters in Washington on Tuesday urged federal officials to reverse course and expand Medicare coverage for the first new FDA-approved treatment for Alzheimer's in nearly two decades.

Around 100 activists rallied outside Health and Human Services offices to voice opposition to January's preliminary decision from the Centers for Medicare & ...